Moving epilepsy care closer to home: Dr. Gagandeep Singh and Dr. Meenakshi Sharma

Can bringing epilepsy care to people’s homes improve outcomes? ILAE spoke with two researchers who conducted a randomized trial of home-based care versus clinic-based care in northern India. Those receiving the home-based care, delivered by community health workers, had better outcomes.

La encuesta de ILAE destaca las preocupaciones globales sobre los medicamentos genéricos anticrisis

Los neurólogos de todo el mundo tienen preocupaciones sobre el uso de medicamentos genéricos anticrisis, cuestionando la calidad deficiente o inconsistente, el acceso limitado, el costo y la falta de control regulatorio.

ILAE survey highlights global concerns about generic anti-seizure medications

Neurologists worldwide have concerns about the use of generic anti-seizure medications, including poor or inconsistent quality, limited access, cost, and lack of regulatory control, according to a global survey of health care professionals.

Can community-based interventions help to close the epilepsy treatment gap?

More than 50 million people have epilepsy; about 80% live in lower- or middle-income countries, where diagnosis and treatment can be difficult or impossible. The percentage of people with epilepsy that is not receiving treatment is known as the treatment gap; in some countries, this gap exceeds 90%.

Reducing the epilepsy treatment gap in Pakistan: Start small, stay flexible, never give up

In retrospect, Pakistan’s effort to reduce the treatment gap can appear painstakingly planned, like the blueprints for a shopping complex or a neighborhood. But the secret of the country’s success is not rooted in elaborate planning. Nor did it rely on generous funding or government support.